Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. KEQU
stocks logo

KEQU

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Valuation Metrics

The current forward P/E ratio for Kewaunee Scientific Corp (KEQU.O) is 17.62, compared to its 5-year average forward P/E of 12.34. For a more detailed relative valuation and DCF analysis to assess Kewaunee Scientific Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Fair
5Y Average PE
12.34
Current PE
17.62
Overvalued PE
19.50
Undervalued PE
5.19

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
8.34
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
12.78
Undervalued EV/EBITDA
3.90

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
0.48
Current PS
0.00
Overvalued PS
0.76
Undervalued PS
0.20
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areSelling! The selling amount has increased 112.14% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 112.14% over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

KEQU News & Events

Events Timeline

(ET)
2025-09-10
16:11:48
Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year
select
2025-09-10
16:11:16
Kewaunee Scientific announces Q1 EPS of $1.04, up from 74 cents last year
select
2025-03-12 (ET)
2025-03-12
17:11:13
Kewaunee Scientific announces amendment to share repurchase program
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
2.0
06:41 AMPRnewswire
Kewaunee Scientific Fully Repays $23 Million Seller Notes Ahead of Schedule
  • Successful Debt Restructuring: On December 4, 2025, Kewaunee Scientific fully repaid $23 million in Seller Notes ahead of schedule, which not only reduced the company's overall debt burden but also lowered future interest expenses, reflecting prudent capital allocation decisions.
  • Enhanced Financial Flexibility: The repayment was partially funded by an amendment to the loan agreement with PNC Bank, which provided an additional $10 million term loan for the repayment, thereby enhancing the company's financial flexibility to support future organic and inorganic growth strategies.
  • Acquisition Benefits Realized: Kewaunee's successful repayment demonstrates the financial contribution from its acquisition of Nu Aire, indicating significant achievements in consistent financial performance and cash management, which enhances shareholder value creation capabilities.
  • Clear Strategic Direction: Kewaunee stated that the decision to repay debt early aligns with its long-term health strategy, and it will continue to focus on executing key initiatives to drive business growth and enhance market competitiveness.
[object Object]
Preview
2.0
06:13 AMNewsfilter
Kewaunee Scientific Fully Repays $23 Million Seller Notes Ahead of Schedule
  • Successful Debt Restructuring: On December 4, 2025, Kewaunee Scientific fully repaid $23 million in Seller Notes ahead of schedule, demonstrating the company's financial stability and capital allocation capabilities following its acquisition of Nu Aire.
  • Enhanced Financial Flexibility: The repayment was partially funded by an amendment with PNC Bank that provided an additional $10 million term loan, which enhances the company's financial flexibility and supports future organic and inorganic growth strategies.
  • Reduced Interest Expenses: Through successful debt restructuring, Kewaunee lowered its overall debt load and effective interest rate, significantly reducing future interest expenses and improving profitability.
  • Strategic Decision-Making: The Vice President stated that the early repayment reflects a commitment to thoughtful capital allocation, strengthening the company's competitive position in the market and laying a foundation for long-term value creation for shareholders.
[object Object]
Preview
9.5
11-27PRnewswire
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026

  • Financial Results Announcement: Kewaunee Scientific Corporation plans to release its second quarter fiscal year 2026 financial results on December 10, 2025, after trading hours, with details available on their website.

  • Company Overview: Founded in 1906, Kewaunee Scientific is a global leader in laboratory and healthcare furniture, with manufacturing facilities in the U.S. and India, and sales offices in multiple countries.

  • Acquisition of Nu Aire: Kewaunee has acquired Nu Aire, a manufacturer of laboratory products, enhancing its portfolio with items like biological safety cabinets and CO2 incubators.

  • Forward-Looking Statements: The press release includes forward-looking statements that are subject to various risks and uncertainties, which could significantly impact the company's future performance and results.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Kewaunee Scientific Corp (KEQU) stock price today?

The current price of KEQU is 39.27 USD — it has increased 3.21 % in the last trading day.

arrow icon

What is Kewaunee Scientific Corp (KEQU)'s business?

Kewaunee Scientific Corporation is engaged in designing, manufacturing, and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, ultralow freezers, and epoxy resin work surfaces and sinks. Its segments include Domestic and International. The Domestic segment designs, manufactures, and installs scientific and technical furniture. The International segment consists of foreign subsidiaries. The Company's products are sold primarily through purchase orders and contracts submitted by customers through its dealers and its subsidiaries, and a national distributor. It has three manufacturing facilities that are located in Statesville serving the domestic and international markets, and one manufacturing facility is located in Bangalore, India serving the local, Asian, and African markets.

arrow icon

What is the price predicton of KEQU Stock?

Wall Street analysts forecast KEQU stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for KEQU is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Kewaunee Scientific Corp (KEQU)'s revenue for the last quarter?

Kewaunee Scientific Corp revenue for the last quarter amounts to 71.10M USD, increased 46.93 % YoY.

arrow icon

What is Kewaunee Scientific Corp (KEQU)'s earnings per share (EPS) for the last quarter?

Kewaunee Scientific Corp. EPS for the last quarter amounts to 1.04 USD, increased 40.54 % YoY.

arrow icon

What changes have occurred in the market's expectations for Kewaunee Scientific Corp (KEQU)'s fundamentals?

The market is revising No Change the revenue expectations for KEQU for , with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by -26.91%.
arrow icon

How many employees does Kewaunee Scientific Corp (KEQU). have?

Kewaunee Scientific Corp (KEQU) has 1239 emplpoyees as of December 05 2025.

arrow icon

What is Kewaunee Scientific Corp (KEQU) market cap?

Today KEQU has the market capitalization of 112.54M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free